Jiangxi Bilin Industrial Co., Ltd. announced that it would receive CNY 20,000,000 in an equity round of funding from new investor Zhejiang Hisoar Pharmaceutical Co., Ltd. on January 28, 2022. After completion of the transaction, the investor will hold 34% stake in the company. The transaction has been reviewed and approved at the 18th meeting of the 6th board of directors of the investor, and does not need to be submitted to the general meeting of its shareholders for consideration.